These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30594572)
1. The best DEFENSE for high-risk patent foramen ovale: An updated meta-analysis of six randomized trials. Kokkinidis DG; Palaiodimos L; Mastoris I; Karamanis D; Faillace RT Arch Cardiovasc Dis; 2019 Mar; 112(3):150-152. PubMed ID: 30594572 [No Abstract] [Full Text] [Related]
2. Closure of patent foramen ovale and "cryptogenic" stroke: What's new, what's next? Mas JL Arch Cardiovasc Dis; 2019 Mar; 112(3):145-149. PubMed ID: 30792077 [No Abstract] [Full Text] [Related]
3. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials. Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192 [TBL] [Abstract][Full Text] [Related]
4. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials. Vidale S; Russo F; Campana C; Agostoni E Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651 [TBL] [Abstract][Full Text] [Related]
5. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929 [TBL] [Abstract][Full Text] [Related]
6. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis. Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819 [TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention. Yuan K; Kasner SE Stroke Vasc Neurol; 2018 Jun; 3(2):84-91. PubMed ID: 30022802 [TBL] [Abstract][Full Text] [Related]
11. Stroke prevention by percutaneous closure of patent foramen ovale: a meta-analytic review. Nagaraja V; Eslick GD Int J Cardiol; 2014 Mar; 172(2):524-6. PubMed ID: 24485622 [No Abstract] [Full Text] [Related]
12. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials. Pasceri V; Pelliccia F; Bressi E; Mantione L; Gaudio C; Speciale G; Mehran R; Dangas GD; Patti G Int J Cardiol; 2018 Sep; 266():75-80. PubMed ID: 29887476 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Kwong JS; Lam YY; Yu CM Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous Closure of Patent Foramen Ovale in Migraine: A Meta-Analysis of Randomized Clinical Trials. Kheiri B; Abdalla A; Osman M; Ahmed S; Hassan M; Bachuwa G; Bhatt DL JACC Cardiovasc Interv; 2018 Apr; 11(8):816-818. PubMed ID: 29673517 [No Abstract] [Full Text] [Related]
15. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials. Wang TKM; Wang MTM; Ruygrok P Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754 [TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis. Zhang XL; Kang LN; Wang L; Xu B BMC Cardiovasc Disord; 2018 Mar; 18(1):45. PubMed ID: 29499641 [TBL] [Abstract][Full Text] [Related]
18. Brief history of patent foramen ovale and stroke. Furlan AJ Stroke; 2015 Feb; 46(2):e35-7. PubMed ID: 25586831 [No Abstract] [Full Text] [Related]
19. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W; Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale does not reduce the risk of recurrent ischemic stroke versus medical therapy alone: a meta-analysis of randomized controlled trials. Zhang B; Zhou J; Li H; Zhou M; Chen A; Zhao Q Int J Cardiol; 2013 Nov; 169(6):e106-8. PubMed ID: 24383119 [No Abstract] [Full Text] [Related] [Next] [New Search]